FDA 483 - Amneal Pharmaceuticals Private Limited - March 19, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Amneal Pharmaceuticals Private Limited, a sterile drug manufacturer in Palli, Gujarat, India, was cited for significant deficiencies during an FDA inspection. The firm failed to thoroughly investigate product discrepancies, lacked adequate production and process control procedures, and exhibited poor laboratory control practices, including issues with Bacterial Endotoxin Testing. Additionally, the quality control unit failed to maintain proper oversight of document destruction.
ID · b39f544d-9145-4ba1-ba6c-e6f50c5aa4b8